Every material Form 8-K 908 Devices Inc. has filed with the SEC since May 06, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
908 Devices reported second-quarter 2026 revenue of $16.1 million, up 23% from a year earlier, and narrowed its net loss from continuing operations to $11.9 million from $12.9 million. The company raised the low end of its full-year 2026 revenue guidance to $68.0 million to $70.0 million, which represents 21% to 25% growth over 2025 revenue. Cash, cash equivalents and marketable securities were $101.5 million at June 30, 2026, with no debt outstanding.
Q2 2026 revenue was $16.1 million, up 23% year over year; recurring revenue was $4.9 million, or 31% of total revenue.
Adjusted EBITDA loss narrowed to $1.9 million from $3.9 million a year earlier.
2026 revenue guidance now $68.0 million to $70.0 million, up from $67.0 million to $70.0 million at the low end.
Cash position of $101.5 million at June 30, 2026, with no debt outstanding.
On July 8, 2026, 908 Devices issued 3,213,583 shares of common stock to satisfy its earnout obligations under the April 29, 2024 Equity Purchase Agreement with RedWave Technology. The contingent right covered up to 4,000,000 shares, tied to RedWave revenue of at least $37 million from May 1, 2024 through April 30, 2026, and the company states the obligations are satisfied in full. The new shares increase the number of shares outstanding, so existing shareholders' ownership stakes are diluted by that amount; the filing does not state the revenue achieved.
Issued 3,213,583 shares of common stock on July 8, 2026.
Earnout could have paid up to 4,000,000 shares to the Seller Entity and other beneficial sellers.
Payout depended on RedWave product and service revenue of at least $37 million from May 1, 2024 through April 30, 2026.
The company states its earnout obligations have been satisfied in full.
908 Devices reported first quarter 2026 revenue of $13.4 million, up 14% year over year, and raised its full-year 2026 revenue outlook to $67.0 million to $70.0 million. Net loss from continuing operations widened to $12.0 million from $9.8 million, largely due to a noncash $6.4 million charge tied to contingent consideration. The company also completed its acquisition of NIRLAB SA, a Swiss narcotics-detection company, on May 4, 2026, for a headline price of $15 million, partly paid in company shares.
Q1 2026 revenue was $13.4 million, up 14% from the prior year period; net loss from continuing operations was $12.0 million, versus $9.8 million a year earlier.
2026 revenue guidance was raised to $67.0 million to $70.0 million, representing 19% to 25% growth over 2025 revenue.
NIRLAB acquisition closed May 4, 2026: $15 million headline price, including $13 million in cash and 293,368 company shares, with up to $8 million more in shares tied to revenue milestones by December 31, 2027.
Shares issued to NIRLAB sellers and option holders are subject to a 180-day lock-up period, per the filing.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every 908 Devices Inc. filing is on SEC EDGAR ↗. 8-K briefs of other companies →